Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Compliance Corner: When Is An Action Exempt From FDA's Recall Reporting Requirements?

May 06 2019

• By Elizabeth Orr

MT1712_Compliance Tab_552489361_1200.jpg

Related Content

Magellen Gets Warning Letter On Lead Test Concerns

Oct 24 2017

US FDA drops controversial recall report idea for device enhancements

Oct 16 2014

'Sharing' Organizations Stay In Final Post-Market Cybersecurity Guidance

Dec 29 2016

Additional Topics

Recalls FDA Safety Compliance Quality Enforcement Compliance Corner Quality Control Medical Device

More from Recalls

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
Editorial Standards
Award-Winning Journalism
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Medtech Top 100 Ranking
Data Trackers
FDA Warning Letters

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window